Forcing cancer cells to commit suicide.

Area of Science:

• Cell Biology
• Molecular Oncology
• Pharmacology

Background:

• Apoptosis is a critical, genetically regulated process in multicellular organisms and cancer.
• Dysregulation of apoptosis contributes to cancer development and chemoresistance.
• Molecular pathways of apoptosis are key targets for anticancer drug development.

Purpose of the Study:

• To review promising apoptosis-inducing anticancer therapies.
• To highlight the role of apoptosis in cancer and drug resistance.
• To explore therapeutic strategies targeting both extrinsic and intrinsic apoptotic pathways.

Main Methods:

• Literature review of apoptosis-inducing anticancer therapies.
• Analysis of molecular pathways regulating apoptosis (extrinsic and intrinsic).
• Evaluation of therapeutic targets including Bcl-2 family proteins and p53 pathway.

Main Results:

• Proapoptotic drugs targeting the extrinsic pathway show promising results.
• Intrinsic pathway targets include Bcl-2 family proteins and p53.
• Combination therapies are more effective than monotherapy for inducing apoptosis in tumor cells.

Conclusions:

• Targeting apoptosis pathways is a promising strategy for cancer therapy.
• Selective induction of apoptosis in tumor cells is the goal of novel therapies.
• Combination of various therapeutic strategies offers the most promising results for tumor cell killing.